News | January 13, 2020

Deciphera Pharmaceuticals Provides Corporate Update and Highlights Key 2020 Milestones – Ripretinib Marketing Applications Submitted to Health Canada and Australia’s Therapeutic Goods Administration for Patients with Advanced GIST via the U.S. FDA’s Project...